BSTG — Biostage Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- $75.22m
- $76.34m
Annual income statement for Biostage, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | — | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 11.5 | 7.84 | 8.87 | 5.33 | 8.23 |
| Operating Profit | -11.5 | -7.84 | -8.87 | -5.33 | -8.23 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.9 | -7.53 | -8.33 | -4.87 | -7.98 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.9 | -7.53 | -8.33 | -4.87 | -7.98 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -11.9 | -7.53 | -8.33 | -4.87 | -7.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.9 | -7.53 | -8.33 | -4.87 | -7.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -6.63 | -1.69 | -1.21 | -0.553 | -0.833 |